BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Drug Development

  Cytokinetics HCM Drug Poised to Begin Phase III

  The firm would be moving forward to Phase III for the treatment of hypertrophic cardiomyopathy, which is expected to commence before the end of 2021.

  July 19, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Business

  Rivus Pharmaceuticals Striving for Fundamental Change in Cardio-metabolic Disorders

  Rivus’ CMAs are designed to overcome these illnesses by activating the body’s natural process of mitochondrial uncoupling.

  July 19, 2021

   · 

  3 min read

   · 

  Heather McKenzie
• 

  Job Trends

  BioNTech Buys Kite TCR Cell Therapy Plant to Boost US Trials

  BioNTech indicates the acquisition will add production capacity in support of U.S. clinical trials.

  July 19, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Job Trends

  Frontier Medicines Raises $88.5 Million to Advance Chemoproteomics Program

  Frontier Medicines will support the continued development of the company’s chemoproteomics drug discovery program, including lead asset, an inhibitor of KRASG12C.

  July 19, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  FDA

  Kadmon’s Chronic GVHD Drug Wins First FDA Approval for Company

  On Friday, the agency approved belumosudil as a new treatment option for anyone over 12 with cGVHD after two prior lines of therapy have failed.

  July 19, 2021

   · 

  2 min read

   · 

  Kate Goodwin
• 

  Drug Development

  AB Science Announces Significant Survival Data for Masitinib in ALS

  The recent survival results of Masitinib will help (ALS) patients to live longer. AB Science has successfully established the sweet spot for masitinib in ALS.

  July 19, 2021

   · 

  3 min read

   · 

  Heather McKenzie
• 

  Drug Development

  Meissa’s Intranasal COVID-19 Vaccine Shows Promise in Non-Human Primates

  Meissa’s intranasal vaccine for COVID-19 equals the protection afforded by existing vaccines in the same class of subjects after only a single dose, according to data presented this week at the American Society of Virology annual meeting.

  July 19, 2021

   · 

  4 min read

   · 

  Gail Dutton
• 

  Drug Development

  Merck Receives Highly-Anticipated FDA Approval for Pneumococcal Vaccine

  The CDC Advisory Committee on Immunization Practices is planning a meeting in October to recommend the vaccine’s use in adults.

  July 19, 2021

   · 

  2 min read

   · 

  Mark Terry
• 

  Deals

  J&J Could Explore Little-Known Legal Maneuver as Talc Product Defense

  With billions of dollars at stake in potential legal liabilities, the life sciences giant is exploring a possible solution – bankruptcy of a sort.

  July 19, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Genentech Hemophilia A Drug Displays Long-term Safety, Efficacy

  Genentech’s Hemlibra showed no new safety signals and continued to deliver consistent bleeding control in the final analysis of a long-term, late-stage hemophilia A study.

  July 19, 2021

   · 

  3 min read

   · 

  Brandon May